TWD
AMRX icon

True Wealth Design’s Amneal Pharmaceuticals AMRX Stock Holding History

True Wealth Design’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$710 Hold
41
– – ﹤0.01% 2096
2026
Q1 		$510 Hold
41
– – ﹤0.01% 2041
2025
Q4 		$517 Hold
41
– – ﹤0.01% 1941
2025
Q3 		$411 Buy
41
+39
+1,950% +$350 ﹤0.01% 2068
2025
Q2 		$17 Buy
+2
New +$15 ﹤0.01% 2521

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

True Wealth Design's AMRX Position: Q2 2026 in Review

True Wealth Design held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 41 shares worth $710. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

True Wealth Design first reported a position in AMRX in Q2 2025 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • True Wealth Design held 41 shares of Amneal Pharmaceuticals worth $710 as of Q2 2026.
  • True Wealth Design left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2096 holding.
  • True Wealth Design first reported a position in Amneal Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.